CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000DJ48VT5

Delayed Deutsche Boerse AG 18:35:16 24/05/2024 BST
47.22 EUR +2.14% Intraday chart for CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+1.29%
1 month+0.17%
Date Price Change
24/05/24 47.22 +2.14%
23/05/24 46.23 -1.39%
22/05/24 46.88 -2.03%
21/05/24 47.85 -1.73%
20/05/24 48.69 +0.29%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 06:35 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer DZ BANK
WKN DJ48VT
ISINDE000DJ48VT5
Date issued 31/08/2023
Strike 60
Maturity 20/06/2025 (392 Days)
Parity 1 : 1
Emission price 48.49
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 49.43
Lowest since issue 31.89
Spread 0.08
Spread %0.17%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.38 EUR
Average target price
39.84 EUR
Spread / Average Target
+3.81%
Consensus